CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATION AND REIMBURSEMENT SCENARIO
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Increase in funding for development of new products
3.5.1.2. Increase in number of ESRD patients
3.5.1.3. Rise in incidence of diabetes and hypertension
3.5.1.4. Preferred technique over kidney transplantation
3.5.2. Restraints
3.5.2.1. Reduction in reimbursements for dialysis
3.5.2.2. Risks and complications associated with dialysis
3.5.2.3. Product recall
3.5.3. Opportunities
3.5.3.1. Technological Advancements Leading to Better Adoption
3.5.3.2. Rise in demand for home peritoneal dialysis treatment
3.5.3.3. Untapped Markets in Developing Economies
CHAPTER 4 DIALYSIS MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. HEMODIALYSIS
4.2.1. Market size and forecast
4.2.2. Conventional hemodialysis
4.2.2.1. Market size and forecast
4.2.3. Short daily hemodialysis
4.2.3.1. Market size and forecast
4.2.4. Nocturnal hemodialysis
4.2.4.1. Market size and forecast
4.3. PERITONEAL DIALYSIS
4.3.1. Market size and forecast
4.3.2. Continuous Ambulatory Peritoneal Dialysis (CAPD)
4.3.2.1. Market size and forecast
4.3.3. Automated Peritoneal Dialysis (APD)
4.3.3.1. Market size and forecast
CHAPTER 5 DIALYSIS MARKET, BY PRODUCTS & SERVICES
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. EQUIPMENT
5.2.1. Key market trends
5.2.2. Growth factors and opportunities
5.2.3. Market size and forecast
5.2.4. Dialysis Machines
5.2.4.1. Market size and forecast
5.2.5. Water Treatment Systems
5.2.5.1. Market size and forecast
5.2.6. Others dialysis equipment
5.2.6.1. Market size and forecast
5.3. CONSUMABLES
5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Dialyzers
5.3.4.1. Market size and forecast
5.3.5. Catheters
5.3.5.1. Market size and forecast
5.3.6. Other dialysis consumables
5.3.6.1. Market size and forecast
5.4. DIALYSIS DRUGS
5.4.1. Key market trends
5.4.2. Growth factors and opportunities
5.4.3. Market size and forecast
5.5. SERVICES
5.5.1. Key market trends
5.5.2. Growth factors and opportunities
5.5.3. Market size and forecast
CHAPTER 6 DIALYSIS MARKET, BY END USERS
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. IN-CENTER DIALYSIS
6.2.1. Key market trends
6.2.2. Growth factors and opportunities
6.2.3. Market size and forecast
6.3. HOME DIALYSIS
6.3.1. Key market trends
6.3.2. Growth factors and opportunities
6.3.3. Market size and forecast
CHAPTER 7 DIALYSIS MARKET, BY GEOGRAPHY
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.3.1. U.S. market size and forecast
7.2.3.2. Mexico market size and forecast
7.2.3.3. Canada market size and forecast
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.3.1. UK market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. Germany market size and forecast
7.3.3.4. Rest of Europe market size and forecast
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.3.1. India market size and forecast
7.4.3.2. Japan market size and forecast
7.4.3.3. China market size and forecast
7.4.3.4. Rest of Asia-Pacific market size and forecast
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.3.1. Brazil market size and forecast
7.5.3.2. South Africa market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast
CHAPTER 8 COMPANY PROFILES
8.1. FRESENIUS MEDICAL CARE AG & CO. KGAA
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Business performance
8.1.5. Key strategic moves and developments
8.2. BAXTER INTERNATIONAL, INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Key strategic moves and developments
8.3. DAVITA INC.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance
8.3.5. Key strategic moves and developments
8.4. NIPRO CORPORATION
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance
8.4.5. Key strategic moves and developments
8.5. B. BRAUN AVITUM AG
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance
8.5.5. Key strategic moves and developments
8.6. DIAVERUM DEUTSCHLAND GMBH.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance
8.6.5. Key strategic moves and developments
8.7. NIKKISO CO. LTD.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.7.5. Key strategic moves and developments
8.8. NXSTAGE MEDICAL, INC.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance
8.8.5. Key strategic moves and developments
8.9. MEDICATORS, INC.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Business performance
8.9.5. Key strategic moves and developments
8.10. ASAHI KASEI CORPORATION
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Business performance
8.10.5. Key strategic moves and developments